Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Previous work has reported the important links between cellular bioenergetics and the development of chronic kidney disease, highlighting the potential for targeting metabolic functions to regulate disease progression. More recently, it has been shown that alterations in fatty acid oxidation (FAO) c...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JCI Insight
Κύριοι συγγραφείς: Price, Nathan L., Miguel, Verónica, Ding, Wen, Singh, Abhishek K., Malik, Shipra, Rotllan, Noemi, Moshnikova, Anna, Toczek, Jakub, Zeiss, Caroline, Sadeghi, Mehran M., Arias, Noemi, Baldán, Ángel, Andreev, Oleg A., Rodríguez-Puyol, Diego, Bahal, Raman, Reshetnyak, Yana K., Suárez, Yajaira, Fernández-Hernando, Carlos, Lamas, Santiago
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Clinical Investigation 2019
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948871/
https://ncbi.nlm.nih.gov/pubmed/31613798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.131102
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια